Company / Current Assets
Revolution Medicines, Inc. Current Assets History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$2.1B
FY2025
5-year range
$589.8M / $2.3B
FY2021-FY2025
Trend
-10.9%
vs FY2024
Sector context
#30 of 213
Health Care
What the data says
Revolution Medicines, Inc.'s current assets of $2.1B is higher than 86% of companies in the Health Care sector (FY2025). Improved from $1.9B to $2.1B over the past 2 years.
Based on SEC 10-K filings.
$2.1B in FY2025 with a 5-year CAGR of +35.5%. Top quartile in the Health Care sector.
Improved from $1.9B to $2.1B over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +46.5%
- 5-Year CAGR
- +35.5%
- 10-Year CAGR
- -
Sector benchmark
Top 14% in Health CareTop 14% of 213This company $2.1B Sector average $2.5B
▼
-17.7% below sector average
Key checks
Key Insights
- 5-year CAGR of +35.5%, indicating consistent growth.
- In FY2025, current assets decreased 10.9% year-over-year.
- Ranks #30 out of 213 companies in the Health Care sector.
- Peak current assets was recorded in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -1.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.1B | -10.9% |
| FY2024 | $2.3B | +23.9% |
| FY2023 | $1.9B | +184.7% |
| FY2022 | $660.2M | +11.9% |
| FY2021 | $589.8M | +29.9% |
| FY2020 | $454.1M | +238.9% |
| FY2019 | $134.0M | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026